BRIGHTSPRING HEALTH SERVICES
BTSGNASDAQTrading Snapshot
- Day Range
- $57.33 – $58.72
- 52-Week Range
- $20.08 – $73.75
- Volume
- $2.63B
- Avg Volume
- $2.91B
- Shares Outstanding
- 197.3M
- Next Earnings
- Oct 14, 2026
Fundamentals Snapshot
- Annual Revenue
- $14.37B
- Last Q Revenue
- $3.92B
- P/E Ratio
- 33.8
- P/S Ratio
- 0.9x
- EPS (TTM)
- $1.66
- Dividend Yield
- —
Why Investors Own BTSG
- ✓High-growth profile — revenue up +53.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 29% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About BRIGHTSPRING HEALTH SERVICES
A company profile for BRIGHTSPRING HEALTH SERVICES isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Carillon Eagle Small Cap Growth Fund Q2 2026 Portfolio Review
Bloom Energy's stock performed well as market adoption for its fuel cell offering continued to gain steam among some of the largest participants in the global AI infrastructure buildout.
BrightSpring Health Services: A Great Business, But I'm Waiting For A Better Entry
BrightSpring Health Services (BTSG) analysis: strong 22% revenue CAGR, Onco360 and Provider Solutions growth, but limited valuation upside.
5 Revealing Analyst Questions From BrightSpring Health Services’s Q2 Earnings Call
BrightSpring Health Services delivered revenue and adjusted profit above Wall Street expectations in Q2, but the market’s negative reaction reflected concerns about underlying headwinds. Management attributed strong year-over-year growth to continued expansion in its Specialty and Infusion pharmacy business, alongside disciplined operational execution and efficiency gains from technology investments. CEO Jon Rousseau detailed that "our Specialty and Infusion business delivered revenue growth of
BrightSpring Health (BTSG) Q2 2026 Earnings Call Transcript
CEO Rousseau discusses specialty pharmacy expansion and integration of recent acquisitions.
BrightSpring Q2 Earnings Call Highlights Growth and Raised Outlook
BTSG Health Services raises its 2026 outlook as Pharmacy and Provider growth, margin gains and lower leverage strengthen operating momentum.
4 Healthcare Stocks to Watch as Defensive Demand Strengthens
Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improving earnings outlooks and steady sector momentum.